Antigen was synthesized with L-SCP, a sea cucumber polysaccharide isolated from Pearsonothuria graeffei (Semper) and bovine serum albumin (BSA) as a carrier protein. Spleen cells with high titer antibody producing ability were removed and fused with myeloma cells of SP2/0-Ag14 origin. Three stable murine monoclonal antibodies (MAb ascites) producing cell lines to L-SCP were generated according to a conventional immunization protocol. Their epitope mapping and binding specificity, which was characterized by blocking and inhibition enzyme-linked immunosorbent assay (ELISA) indicated that these specific MAb ascites have similar binding patterns. A sandwich ELISA was developed on the basis of employing L-SCP specific antibodies including MAb 3G6 as capture antibody and HRP-3G6 as detection antibody. The working range for L-SCP in aqueous solution from this method was 100–10,000 ng/mL with good sensitivity, specificity, and precision (relative standard deviation ≤7.9%). Thus the developed ELISA can be used as a convenient tool for the rapid detection of L-SCP in biological examples in the future.
Get full access to this article
View all access options for this article.
References
1.
BattagleneSC, SeymourJE, RamofafiaC. Survival and growth of cultured juvenile sea cucumbers, Holothuria scabra. Aquaculture, 1999; 178:239–322.
2.
FuXV, XueCH, MiaoBC, LiZJ, GaoX, YangWG. Characterization of proteases from the digestive tract of sea cucumber (Stichopus japonicus): High alkaline protease activity. Aquaculture, 2005; 246:321–329.
3.
BorsigL, WangL, CavalcanteMC, Cardilo-ReisL, FerreiraPL, MouraoPA, EskoJD, PavãoMS. Selectin blocking activity of a fucosylated chondroitin sulfate glycosaminoglycan from sea cucumber. Effect on tumor metastasis and neutrophil recruitment. J Biol Chem, 2007; 282:14984–14991.
4.
Tapon-BretaudiereJ, ChabutD, ZiererM, MatouS, HelleyD, BrosA, MouraoPA, FischerAM. A fucosylated chondroitin sulfate from echinoderm modulates in vitro fibroblast growth factor 2-dependent angiogenesis. Mol Cancer Res, 2002; 1:96–102.
5.
NagaseH, EnjyojiK, MinamiguchiK, KitazatoKT, KitazatoK, SaitoH, KatoH. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin. Blood, 1995; 85:1527–1534.
6.
NagaseH, EnjyojiK, ShimaM, KitazatoK, YoshiokaA, SaitoH, KatoH. Effect of depolymerized holothurian glycosaminoglycan (DHG) on the activation of factor VIII and factor V by thrombin. J Biochem, 1996; 119:63–69.
7.
SheehanJP, WalkeEN. Depolymerized holothurian glycosaminoglycan and heparin inhibit the intrinsic tenase complex by a common antithrombin-independent mechanism. Blood, 2006; 107:3876–3882.
8.
BuyueY, SheehanJP. Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite. Blood, 2009; 114:3092–3100.
9.
LiJ, LianE. Aggregation of human platelets by acidic mucopolysaccharide extracted from Stichopus japonicas Selenka. J Thromb Haemost, 1988; 59:435–439.
10.
StudelskaDR, GiljumK, McDowellLM, ZhangL. Quantification of glycosaminoglycans by reversed-phase HPLC separation of fluorescent isoindole derivatives. Glycobiology, 2006; 16:65–72.
11.
ShaferDE, TollB, SchumanRF, NelsonBL, MondJJ, LeesA. Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) for use in protein-polysaccharide conjugate vaccines and immunological reagents. II. Selective crosslinking of proteins to CDAP-activated polysaccharides. Vaccine, 2000; 18:1273–1281.
12.
ScottT, MelvinEH. Determination of dextran with anthrone. Anal Chem, 1953; 25:1656–1661.
13.
LowryOH, RosebroughNJ, FarrAJ, RandallRJ. Protein measurement with the Folin phenol reagent. J Biol Chem, 1951; 193:265–275.
14.
ZhouXL, ZhaoH, GaoXD. Preparation and characterization of monoclonal antibodies against a polysaccharide from Flammulina velutipes Mycelium. Hybridoma, 2008; 27:439–444.
15.
TijssenP, KurstakP. Highly efficient and simple methods for the preparation of peroxidase and active peroxidase-antibody conjugates for enzyme immunoassays. Anal Biochem, 1984; 136:451–457.
16.
FriguetB, ChaffotteAF, Djavadi-OhanianceL, GoldbergME. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J Immunol Meth, 1985; 77:305–319.
17.
YangTB, ZhongP, QuL, WangCY, YuanYH. Preparation and identification of anti-2, 4-dinitrophenyl monoclonal antibodies. J Immunol Meth, 2006; 313:20–28.
18.
FonsecaRJ, MouraoPA. Fucosylated chondroitin sulfate as a new oral antithrombotic agent. Thromb Haemostasis, 2006; 96:822–829.
19.
MouraoPA, Boisson-VidalC, Tapon-BretaudiereJ, DrouetB, BrosA, FischerA. Inactivation of thrombin by a fucosylated chondroitin sulfate from echinoderm. Thromb Res, 2001; 102:167–176.
ZuñigaJ, LilloL, ShinJJ, MachavarapuRL, QuirogaT, GoycooleaM, MatsuhiroB, Aron-HottL, GodfreyHP, CabelloFC. Salmonella enterica serovar Typhi O:1,9,12 polysaccharide-protein conjugate as a diagnostic tool for typhoid fever. J Clin Microbiol, 2005; 43:4545–4550.
22.
MoranE, KeeffeMO, ConnorRO, LarkinAM, MurphyP, ClynesM. Methods for generation of monoclonal antibodies to the very small drug hapten, 5-benzimidazolecarboxylic acid. J Immunol Meth, 2002; 271:65–67.
23.
ZhaoH, FengW, ZhangH, ZhouXL, XuSY, GaoXD. Production of monoclonal antibodies for detecting Marine fungal polysaccharide isolated from the Phoma herbarum YS4108. Immunol Invest, 2008; 37:770–781.
